drugset / Trial / NCT01489319

Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)

NCT01489319

Phase 1 Terminated 47 enrolled Indiana University
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to determine the relationship between lipid-induced inflammation and ovarian androgen secretion in women with polycystic ovary syndrome (PCOS); and to examine the effect of salsalate and polygonum cuspidatum extract (PCE) containing resveratrol on lipid-induced inflammation, ovarian androgen secretion, body composition and ovulation in a subset of normal weight women with PCOS.

Timeline

Start
2012-02
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Salsalate Small molecule 2 g
Subject polygonum cuspidatum extract Unknown 200 mg